ASSET
Published on ASSET (http://www.asset-scienceinsociety.eu)

Home > Taxonomy term

synthetic biology

MycoSynVac: synthetic biology, paying attention to ethical issues

Thursday, September 22, 2016 - 09:11

Vaccines have had broad medical impact, but existing vaccine technologies and production methods are limited in their ability to respond to certain pathogens. Other hurdles are due to difficulties in large scale production. MycoSynVac project proposes a new way for developing vaccines, by using of cutting-edge synthetic biology methodologies to engineer Mycoplasma pneumoniae as a universal chassis for vaccination.

  • Read more about MycoSynVac: synthetic biology, paying attention to ethical issues
Target: 
Industry & Commerce
Topic: 
Microbiology, Stakeholders, Vaccination
Tags: 
Vaccine, ethics, synthetic biology

Newsletters

Select the newsletter(s) to which you want to subscribe or unsubscribe.

News from Asset project
Responsible Research and Innovation Newsletter
Asset PPRB
E-mail *

Contacts

Facebook
Twitter
YouTube
LinkedIn

Contacts

General inquiries: info@asset-scienceinsociety.eu

ASSET

Action plan on Science in Society related issues in Epidemics and Total pandemics
European Commission
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 612236.

Source URL: http://www.asset-scienceinsociety.eu/tags/synthetic-biology